Life Sciences Directory

Takeda is a leading, values-based, R&D-driven, biopharmaceutical company headquartered in Japan. Takeda's mission is to develop and produce life-transforming medicines for the treatment of rare and complex diseases. The focus is on the supply of patients for whom no or only a few treatment options are available. At Takeda in Austria, every step of the process for innovative medicines takes place: from research and development, plasma sourcing and manufacturing to patient supply.

Translation and Reproducibility - Standardized HUMAN Biomaterials: THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components.

TissueGnostics provides fully integrated cutting-edge tissue cytometers for (i) whole-slide imaging (brightfield, fluorescence, confocal, multispectral) and (ii) high-end analysis of tissue sections, cultured cells, TMAs, smears etc. Explore TGs solutions for spatial phenotyping, single cell analysis, molecular single cell profiling, machine-learning based tissue classification and many more.

UpNano develops, manufactures and commercializes high resolution 3D printers. With the unique speed and precision, microparts from 200 Nanometer up to 40mm in size can be printed. As a spin out of the TU Wien, UpNano has built an international business since early 2019 with a subsidiary in Boston and sold machines all over the world. Applications in med tech, optic- and electronic industry but also in academic research have supported a growth in 2023 of 55% of the business over 2022.

usePAT offers add-on devices for the improvement of in-line measurements in PAT (Process Analytical Technology) systems. They are compatible with a variety of sensors and can be designed and adapted to the specific needs and requirements of many fields of application. In order to facilitate the process of real-time measuring, our technology takes advantage of well-controlled ultrasonic fields for spatial particle manipulation in liquids.

VALIDOGEN, formerly known as VTU Technology, is a leading Austrian contract research and development company. VALIDOGEN offers UNLOCK PICHIA - the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein production. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression. VALIDOGEN has established a broad range of tools and know-how for the generation of high-performance Pichia processes. Exclusive proprietary technologies and profound experience of the VALIDOGEN team lead to competitive production processes for a wide range of recombinant proteins. Headquartered in Raaba-Grambach, near Graz, Austria, VALIDOGEN is a private company and independent subsidiary of the KonValue Holding GmbH.

VERDI Solutions GmbH, a Vienna-based startup, develops cutting-edge technology for personalized cancer vaccines. Our innovations include diagnostic tests for HLA-based T-cell responses, HLA expression analysis, and personalized vaccine target identification. Our proprietary software predicts the immunogenicity, safety, and quality of vaccines at the individual level. Our mission is to provide safe, effective personalized vaccines to improve the health of cancer patients.